Monash-led study unveils potential long-term treatment for lupus

Researchers assessed Smith (Sm)-specific regulatory T cells (Tregs) efficacy in halting lupus nephritis (LN) by engineering and testing epitope-targeted Tregs for systemic lupus erythematosus (SLE) treatment.

Otsuka terminates Alzheimer’s agitation drug after failed Phase 3

Otsuka ended development of AVP-786 after the experimental Alzheimer’s disease treatment failed a late-stage study earlier this year. The company made the decision to terminate

May 23, 2024

Zetaris Unveils AI Studio for Disease Detection and Diagnosis

What You Should Know: Zetaris, the provider of the AI-Powered Lakehouse, today unveils its game changing AI studio designed specifically for healthcare and life science professionals

March 14, 2024

Study finds interleukin-24 enhances CAR-T cell therapy’s effectiveness against cancer stem cells

The effect of Interleukin-24 (IL-24) on CSCs and CAR-T cell therapy.

February 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.